You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 9,980,944


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,980,944 protect, and when does it expire?

Patent 9,980,944 protects MEKTOVI and is included in one NDA.

This patent has twenty-nine patent family members in eighteen countries.

Summary for Patent: 9,980,944
Title:Preparation of and formulation comprising a MEK inhibitor
Abstract: The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-car- boxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-car- boxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.
Inventor(s): Krell; Christoph Max (Basel, CH), Misun; Marian (Basel, CH), Niederer; Daniel Andreas (Basel, CH), Pachinger; Werner Heinz (Basel, CH), Wolf; Marie-Christine (Basel, CH), Zimmermann; Daniel (Basel, CH), Liu; Weidong (Boulder, CO), Stengel; Peter J. (Boulder, CO), Nichols; Paul (Boulder, CO)
Assignee: Array BioPharma Inc. (Boulder, CO)
Application Number:15/445,393
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,980,944
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,980,944: A Detailed Analysis

Introduction

United States Patent 9,980,944, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To delve into the specifics of this patent, we need to break down its components and analyze them within the context of U.S. patent law and recent updates.

Patent Overview

What is the Patent About? To begin, it is crucial to understand the subject matter of the patent. While the specific details of Patent 9,980,944 are not provided here, patents generally describe an invention, its background, a detailed description of the invention, and the claims that define the scope of the invention.

Claims Analysis

Types of Claims Patent claims are the heart of any patent application, as they define the scope of protection sought. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim[3].

Independent Claims

Independent claims in Patent 9,980,944 would outline the broadest scope of the invention. These claims must be clear, concise, and fully supported by the description provided in the patent specification. The length and count of independent claims can influence the patent's scope and the likelihood of its grant, as narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Dependent Claims

Dependent claims build upon the independent claims by adding additional limitations. These claims help to narrow the scope of the invention and can be used to protect various aspects or embodiments of the invention.

Scope of Protection

Determining Patent Scope The scope of a patent is determined by its claims. The USPTO and courts use various metrics to evaluate this scope, including the length and count of independent claims. Longer and more numerous independent claims can indicate a broader scope, but may also increase the risk of rejection during the examination process[3].

Recent USPTO Guidance on AI Patents

Implications for AI-Related Inventions For patents involving AI, such as those that might be related to Patent 9,980,944 if it involves AI technology, the 2024 USPTO guidance update provides critical insights. This update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For example, claims involving AI must demonstrate concrete technological improvements and provide meaningful limits on the abstract ideas they embody[1].

Practical Applications and Real-World Benefits

Example from USPTO Guidance The USPTO guidance includes examples that illustrate how AI-related claims can meet patent eligibility criteria. For instance, Example 48 discusses an AI-based method for analyzing speech signals and separating desired speech from background noise. The claim is considered patent-eligible because it specifies the use of separated audio components in a real-time speech recognition system, thereby providing a practical application that enhances the accuracy of voice commands in hands-free environments[1].

Inventorship and Ownership

Determining True and Only Inventors The validity of a patent also depends on the correct identification of inventors. U.S. patent law requires that only the true and only inventors be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice. Errors in inventorship can lead to the patent being unenforceable if there was deceptive intent involved[5].

Search and Analysis Tools

Utilizing USPTO Resources To analyze the patent landscape and understand the scope of Patent 9,980,944, one can use various tools provided by the USPTO. The Public Search Facility and online databases allow users to search for existing patents, published patent applications, and related documentation. The Global Dossier service provides access to file histories and related applications from participating IP offices, which can be invaluable for understanding the broader patent family and potential prior art[4].

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the scope of the patent. Independent claims should be clear and fully supported by the patent specification.
  • Scope of Protection: The scope is determined by the claims, with narrower claims often having a higher likelihood of grant.
  • AI Patents: Recent USPTO guidance emphasizes integrating judicial exceptions into practical applications to ensure patent eligibility for AI-related inventions.
  • Practical Applications: Claims must demonstrate real-world benefits and concrete technological improvements to be patent-eligible.
  • Inventorship: Correct identification of inventors is crucial for the validity of the patent.

FAQs

  1. What are the key components of a patent claim?

    • Patent claims include independent claims that stand alone and define the invention broadly, and dependent claims that further limit the independent claims.
  2. How does the USPTO determine the patent eligibility of AI-related inventions?

    • The USPTO determines patent eligibility by assessing whether the claim integrates a judicial exception into a practical application, providing meaningful limits on the exception and demonstrating concrete technological improvements.
  3. What is the importance of correct inventorship in a patent application?

    • Correct inventorship is crucial as it ensures the patent's validity. Errors in inventorship, especially with deceptive intent, can render the patent unenforceable.
  4. How can one search for and analyze patents using USPTO resources?

    • One can use the USPTO's Public Search Facility, online databases, and the Global Dossier service to search for patents, access file histories, and analyze related applications.
  5. What metrics are used to evaluate the scope of a patent?

    • Metrics such as independent claim length and independent claim count are used to evaluate the scope of a patent, with narrower claims often associated with a higher probability of grant.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent
    • Mintz, Understanding the 2024 USPTO Guidance Update on AI Patent, July 25, 2024.
  2. U.S. Patent and Trademark Office (USPTO)
    • USA.gov, U.S. Patent and Trademark Office (USPTO).
  3. Patent Claims and Patent Scope
    • SSRN, Patent Claims and Patent Scope, September 29, 2016.
  4. Search for patents - USPTO
    • USPTO, Search for patents, October 18, 2018.
  5. Determining Inventorship for US Patent Applications
    • Oregon State University, Determining Inventorship for US Patent Applications.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,980,944

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Array Biopharma Inc MEKTOVI binimetinib TABLET;ORAL 210498-001 Jun 27, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF MELANOMA WITH A BRAF MUTATION ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 9,980,944

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 099630 ⤷  Try for Free
Brazil 112015008623 ⤷  Try for Free
Canada 2888474 ⤷  Try for Free
Canada 3079071 ⤷  Try for Free
China 104870427 ⤷  Try for Free
China 109336824 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.